Microsure appoints Alex Joseph as CEO for clinical growth phase
Evidence notes
- Microsure appointed Alex Joseph as Chief Executive Officer, succeeding Iwan van Vijfeijken.
- The company framed the leadership transition around its move into clinical execution after MUSA-3 received CE mark approval.
- Joseph has been involved in MUSA-3 development and brings surgical robotics, clinical-environment, and regulated medical-device experience.
Company context
Microsure is a Dutch medical robotics company developing robot-assisted systems for open microsurgery and supermicrosurgery. Its MUSA platform is designed to let surgeons perform high-precision procedures using scaled, tremor-filtered joystick control while retaining their own microsurgical instruments through disposable adapters.